Researchers analysed thousands of laboratory-made plasmids and discovered that nearly half of them had defects, raising questions of experimental reproducibility.
Aggregated News
The Matchright technology will be available in two US fertility clinics later this month, allowing people to screen out sperm donors who, when their genes are combined with those of the intended mother, could increase the risk of a child inheriting genetic diseases. The company that markets the technology, GenePeeks, hopes to expand worldwide.
But the technology's patent also includes a list of traits that aren't necessarily related to health – such as eye and skin pigmentation, height and waist size – raising concerns that it could be used to select embryos on the basis of more superficial characteristics. "It covers any disease or any trait that has a genetic influence," says Lee Silver at Princeton University, who co-founded GenePeeks – even those where the genetic basis has yet to be discovered.
To find...